Tectora Therapeutics is a biotechnology company focused on developing innovative gene‑editing therapies for rare genetic diseases. Leveraging proprietary CRISPR‑based platforms, the firm aims to deliver precise, durable treatments that address the underlying causes of conditions such as Duchenne muscular dystrophy and cystic fibrosis. The company collaborates with leading academic institutions and pharmaceutical partners to advance its pipeline through pre‑clinical and early clinical stages, emphasizing safety, efficacy, and regulatory compliance. Tectora Therapeutics is headquartered in Austin, Texas, and is backed by venture capital investors including NEA.
Tectora Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Gene Editing, Rare Diseases, and Therapeutics.
Regulatory Posture applies to this provider. Its tags matched the
Horizontal (data, software, accessibility, platform) regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
Show this score on your site.
It updates itself when the score changes. Paste this where you link to your API docs:
<a href="https://apis.io/providers/tectora-therapeutics/"><img src="https://apis.io/badge/tectora-therapeutics/card.svg" alt="Tectora Therapeutics on APIs.io — Kin Score by API Evangelist"></a>
Other styles, a README pill and a shields.io endpoint are on the badge page.
Raise your score.
Agent readiness — checks not met, largest first (exact, from this profile):
Machine-Readable Auth+10 pts — a served openid-configuration/oauth-authorization-server carrying `issuer` (served), else the securitySchemes class in the provider OpenAPIs — bound (mutualTLS, DPoP, Signature) > negotiable (oauth2 authorizationCode/clientCredentials, openIdConnect) > bearer (http bearer, apiKey)
Idempotency+9 pts — OpenAPI mutating operations declare an idempotency key — a header, a request-body property, or a named de-duplication token whose own description says so (verified); else common[].type matches /idempoten/i (documented)
A2A Agent Card+8 pts — a2a/-a2a.yml manifest, graded on conformance.grade against A2A 1.0.0
Stable Error Semantics+8 pts — OpenAPI $refs a shared error schema across 4xx/5xx responses (verified), else common[].type includes ErrorCatalog / ErrorCodes / DeclineCodes
12 more unmet checks in the Agent Readiness table above.
Kin Score — facets with the most composite points still available (weight × headroom):
aid: tectora-therapeutics
name: Tectora Therapeutics
image: https://tectoratx.com/og-image.png
description: Tectora Therapeutics is a biotechnology company focused on developing innovative gene‑editing therapies for rare
genetic diseases. Leveraging proprietary CRISPR‑based platforms, the firm aims to deliver precise, durable treatments that
address the underlying causes of conditions such as Duchenne muscular dystrophy and cystic fibrosis. The company collaborates
with leading academic institutions and pharmaceutical partners to advance its pipeline through pre‑clinical and early clinical
stages, emphasizing safety, efficacy, and regulatory compliance. Tectora Therapeutics is headquartered in Austin, Texas,
and is backed by venture capital investors including NEA.
url: https://raw.githubusercontent.com/api-evangelist/tectora-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:vc-portfolio
x-tier: profiled
x-tier-reason: enrichment pass 2026-10-23 (modular-v1; was harvest)
specificationVersion: '0.20'
created: '2026-10-22'
modified: '2026-10-22'
tags:
- Company
- Biotechnology
- Gene Editing
- Rare Diseases
- Therapeutics
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Hosts
url: hosts/tectora-therapeutics-hosts.yml
- type: Vendors
url: vendors/tectora-therapeutics-vendors.yml
- type: DomainSecurity
url: security/tectora-therapeutics-domain-security.yml
- type: Website
url: https://tectoratx.com/
apis: []
x-backed-by:
- nea
x-coverage:
state: none
reason: no-developer-program
method: derived
generated: '2026-10-23'
generator: derive-coverage.py (pre-flight evidence)
detail: the company publishes no developer documentation host and no machine-readable contract on its own domain
evidence:
- url: https://tectoratx.com/
status: 200
x-enrichment:
date: '2026-10-23'
status: enriched
artifacts_added: 7
pass: modular-v1
engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.